Amgen Report on Nuzzel

reuters.com - Reuters Editorial - Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Reuters – Reuters Editorial
patentdocs.org - Supreme Court Denies Certiorari in Amgen v. Sanofi

Supreme Court Denies Certiorari in Amgen v. Sanofi

patentdocs.org
pacbiztimes.com - FDA committee OKs Amgen's Evenity

FDA committee OKs Amgen's Evenity

Pacific Coast Business Times
worldpharmanews.com - Amgen and UCB receive positive vote from FDA Advisory Committee in favor of approval for EVENITY™ (romosozumab)

Amgen and UCB receive positive vote from FDA Advisory Committee in favor of approval for EVENITY™ (romosozumab)

worldpharmanews.com
reuters.com - Saumya Joseph and Aakash B - Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Reuters – Saumya Joseph and Aakash B
statnews.com - Ed Silverman - Pharmalittle: FDA panel backs Amgen osteoporosis drug

Pharmalittle: FDA panel backs Amgen osteoporosis drug

STAT – Ed Silverman
xconomy.com - Frank Vinluan - FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks

FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks

Xconomy – Frank Vinluan
dividend-growth-stocks.com - D4l - Amgen, Inc. (AMGN) Dividend Stock Analysis

Amgen, Inc. (AMGN) Dividend Stock Analysis

Dividend Growth Stocks – D4l
biopharmadive.com - Suzanne Elvidge - Amgen's osteoporosis drug faces safety scrutiny from FDA

Amgen's osteoporosis drug faces safety scrutiny from FDA

BioPharma Dive – Suzanne Elvidge

Top Sources reporting on Amgen

Name
1 Modern Readers
2 Endpoints News
3 Reuters
4 Yahoo
5 EIN News
6 Cyclingnews.com